Hester Biosciences Ltd. share price target

Hester Biosciences is a 25 year old company specialized in the manufacturing of advanced veterinary vaccines. HBSL is the second largest poultry vaccine manufacturer in India & operates one of the largest single location animal manufacturing units in Asia. Its primary manufacturing facility is located in Merda-Arday, in Gujarat and has a large product basket of 39 live and inactivated vaccines. HBSL has a facility in Nepal which is a 100% export oriented unit, aimed at expanding reach to the markets of Nigeria, Sudan,...

PPR Eradication Program by FAO - A Tremendous Opportunity for Hester: Food and Agriculture Organization (FAO) has embarked on a mission to eradicate PPR disease (plague affecting Sheep and Goats) and has planned to spend about US$ 7.6 Bn over a span of 15 years starting 2015. Annual spend on PPR vaccines will be about US$ 0.5 Bn in the initial stages. This is a tremendous opportunity and HBL (Hester Biosciences Ltd.) has already set up a plant in Nepal to manufacture and export PPR vaccines worldwide. Nepal plant is expected to start operations in Oct 2015. Hester has already begun establishing cold storage and distribution networks, the backbone of vaccines business, across southern and eastern Africa. International manufacturers have priced the vaccine at 10 US cents per dose, but Hester would be aggressively pricing between 2.5 to 3.5 US cents.